Rare Disorder
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Stakeholders of Rare Diseases Informing Values In Neuroethics (NCT07314736) | St. Jude Children's Research Hospital | 2026-07-08 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
Track Rare Disorder automatically
Every clearance here is in the API, with alerts when new ones post.